5 Must-Read Analyst Questions From AdaptHealth’s Q2 Earnings Call
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of AdaptHealth Corp. (“AdaptHealth”...
AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies,...
AdaptHealth Corp. (NASDAQ: AHCO) shares fell as much as 26% after Q2 revenue of $740.3 million and a $0.99 GAAP loss missed expectations, alongside a $144.2 million goodwill impairment. Levi & Korsinsky...
Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AdaptHealth Corp. (“AdaptHealth” or the...
On May 5, 2026, AdaptHealth raised its full-year 2026 revenue guidance to $3.45 billion to $3.52 billion. Weeks later, the Company reset that guidance to approximately $2.85 billion to $2.89 billion --...
Law Offices of Howard G. Smith announces an investigation on behalf of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO ) investors concerning the Company’s possible...
The Law Offices of Frank R. Cruz announces an investigation of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO ) on behalf of investors concerning the Company’s...
AdaptHealth guided full-year 2026 adjusted EBITDA to $680 million to $730 million on May 5, 2026, and told investors elevated labor costs would normalize. Weeks later the range was reset to approximately...